The U.S. Department of Energy’s National Nuclear Security Administration (NNSA) has agreed to provide supplemental funding for NorthStar Medical Radioisotopes’ medical isotope production venture.

The arrival of the Ebola virus in the United States this year caught at least one medical facility off guard and has prompted officials to rethink response protocols when it comes to the highly fatal, infectious disease.

The Saskatoon, Canada-based Canadian Light Source has reached a major benchmark in the company’s Medical Isotope Project by shipping the first major supply of isotopes, the company announced Friday. Health Canada has yet to approve it, but, with further testing, this technology could begin supplying medical isotopes to medical facilities in the region by 2016.

F-18 mefway is a novel serotonin-1A receptor ligand that could one day be used to image neurodegenerative disease and psychiatric disorders, according to a story published Nov. 13 in the Journal of Nuclear Medicine.

Lantheus Medical Imaging, based in Billerica, Mass., announced the radiopharmaceutical company’s third quarter financials yesterday, revealing an 8 percent increase over the same quarter in 2013.

The Centers for Medicare & Medicaid Services (CMS) issued final rules for the 2015 Hospital Outpatient Prospective Payment System (HOPPS) and the Medicare Physician Fee Schedule (MPFS). The rules were recorded in the Federal Register Nov. 10 and go into effect Jan. 1, 2015. It appears that changes to HOPPS will depress PET payments by 1.9 percent.

Many in the imaging community were thrilled with the decision by the Centers for Medicare & Medicaid Services (CMS) to extend coverage of annual low-dose CT screening to Medicare beneficiaries at high risk for lung cancer, but now the work of educating patients and primary care physicians begins.

Breast cancer specialists at Ohio State University have turned radiation treatment upside down. Literally.